Ivo Petrov - Concepedia

Author

Ivo Petrov

Also Known As

Abtan, J, Alden Begić, Borislav Kolomanov, Christophe Leclercq, I Petrov, I. Petrov, I. S. Petrov, Il Petrov, Ivan Petrov, Ivo PETROV

202

Publications

7.8K

Citations

H-Index

Concepts

All Affiliations

Acibadem City Clinic Imperial College London University Hospital of Bern Institute of Social and Preventive Medicine Grand Charleroi Hospital

About

Ivo Petrov is an author at Acibadem City Clinic specializing in medicine, cardiovascular disease, and surgery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	13	1.6K
2	Engineering	1	1	20
3	Public Health	1	1	285
4	Biomedical Engineering	1	1	20
5	Emergency Medicine	1	1	44

Ivo Petrov

Publications

2.8K

Citations

H-Index

Page 1

	Year	Citations
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial Pascal Vranckx, Marco Valgimigli, Peter Jüni, The Lancet Endovascular TechniqueCardiovascular DiseaseRandomised Superiority TrialLumen-apposing Metal StentPharmacotherapy	2018	761
Reperfusion therapy for ST elevation acute myocardial infarction 2010/2011: current status in 37 ESC countries Steen Dalby Kristensen, Kamilla Grønborg Laut, Jean Fajadet, European Heart Journal	2014	345
Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) Antonio J. Vallejo‐Vaz, Christophe Stevens, Alexander R.M. Lyons, The Lancet Family MedicineMetabolic SyndromeLipid DisorderCardiovascular DiseaseHealth Policy	2021	285
Polymer-based or Polymer-free Stents in Patients at High Bleeding Risk Stephan Windecker, Azeem Latib, Elvin Kedhi, New England Journal of Medicine	2020	279
Cardiopoietic cell therapy for advanced ischemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial Jozef Bartúnek, André Terzic, Beth A. Davison, European Heart Journal	2016	180
Ticagrelor Alone Versus Dual Antiplatelet Therapy From 1 Month After Drug-Eluting Coronary Stenting Anna Franzone, Eugène McFadden, Sergio Leonardi, Journal of the American College of Cardiology Percutaneous Coronary InterventionThrombosisCardiovascular DiseasePharmacologyCardiology	2019	145
Safety and efficacy of a sirolimus-eluting coronary stent with ultra-thin strut for treatment of atherosclerotic lesions (TALENT): a prospective multicentre randomised controlled trial Azfar Zaman, Robbert J. de Winter, Norihiro Kogame, The Lancet Percutaneous Coronary InterventionAtherosclerotic LesionsEndovascular TechniqueCardiovascular DiseaseCardiology	2019	94
Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study Kanika Dharmayat, Antonio J. Vallejo‐Vaz, Christophe Stevens, The Lancet	2023	71
Safety Profile of Endovascular Treatment for Chronic Cerebrospinal Venous Insufficiency in Patients With Multiple Sclerosis Ivo Petrov, L Grozdinski, Genadi Kaninski, Journal of Endovascular Therapy	2011	67
PRECISE-DAPT score for bleeding risk prediction in patients on dual or single antiplatelet regimens: insights from the GLOBAL LEADERS and GLASSY Felice Gragnano, Dik Heg, Anna Franzone, European Heart Journal - Cardiovascular Pharmacotherapy	2020	62

Page 1